drugset / Trial / NCT05737082
A Study to Evaluate the Pharmacokinetics and Safety Between HCP2201 and Co-administration of Each Component in Healty Male Volunteers
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to evaluate the pharmacokinetic characteristics and safety between HCP2201 and co-administration of each component in fasting condition in healthy male volunteers.
Timeline
- Start
- 2023-03-30
- Primary completion
- 2023-05-14
- Completion
- 2023-05-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HCP2201 | Unknown | — | — |
| Subject | RLD2205 | Unknown | — | — |
| Subject | RLD2206 | Unknown | — | — |
Indications
No indication recorded.